The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Lilly
Travel, Accommodations, Expenses - Pfizer
Other Relationship - Lilly O.
Primary outcome analysis of the phase 3 SONIA trial (BOOG 2017-03) on selecting the optimal position of cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors for patients with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC).
 
Gabe S. Sonke
Consulting or Advisory Role - Biovica (Inst); Novartis (Inst); Seagen (Inst)
Research Funding - Agendia (Inst); AstraZeneca/Merck (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst); Seagen (Inst)
 
Annemiek Van Ommen - Nijhof
No Relationships to Disclose
 
Noor Wortelboer
No Relationships to Disclose
 
Vincent van der Noort
No Relationships to Disclose
 
Astrid C. P. Swinkels
No Relationships to Disclose
 
Hedwig M. Blommestein
No Relationships to Disclose
 
Aart Beeker
No Relationships to Disclose
 
Karin Beelen
No Relationships to Disclose
 
Lisanne C. Hamming
No Relationships to Disclose
 
Joan B. Heijns
No Relationships to Disclose
 
Aafke H. Honkoop
No Relationships to Disclose
 
Paul C. De Jong
No Relationships to Disclose
 
Quirine C. Van Rossum-Schornagel
Consulting or Advisory Role - Roche
 
Christa van Schaik-van de Mheen
No Relationships to Disclose
 
Jolien Tol
No Relationships to Disclose
 
Cathrien Tromp-Van Driel
No Relationships to Disclose
 
Suzan Vrijaldenhoven
No Relationships to Disclose
 
A. Elise Van Leeuwen-Stok
No Relationships to Disclose
 
Inge Konings
Research Funding - Novartis (Inst)
 
Agnes Jager
No Relationships to Disclose